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1. Introduction {#mbo3432-sec-0001}
===============

The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) emphasized an urgent need for the development of antimicrobials with novel modes of action against antibiotic‐resistant threats with severe consequences for public health, including infections caused by drug‐resistant *Neisseria gonorrhoeae* (Centers for Disease Control and Prevention, [2013a](#mbo3432-bib-0012){ref-type="ref"}, [2013b](#mbo3432-bib-0013){ref-type="ref"}; World Health Organization, [2012](#mbo3432-bib-0073){ref-type="ref"}, [2015](#mbo3432-bib-0074){ref-type="ref"}). Gonorrhea is highly prevalent throughout the world, and if untreated or inadequately treated, often leads to serious repercussions on reproductive health including ectopic pregnancy, pelvic inflammatory disease, and infertility (Centers For Disease Control And Prevention, [2013b](#mbo3432-bib-0013){ref-type="ref"}, Low, Unemo, Skov Jensen, Breuer, & Stephenson, [2014](#mbo3432-bib-0046){ref-type="ref"}; World Health Organization, [2011](#mbo3432-bib-0072){ref-type="ref"}). In the absence of a protective gonorrhea vaccine, antibiotics remain the sole therapeutic intervention. However, the well‐documented ability of gonococci to acquire antibiotic resistance continues to threaten available treatment options (Unemo, [2015](#mbo3432-bib-0068){ref-type="ref"}; Unemo & Shafer, [2014](#mbo3432-bib-0070){ref-type="ref"}). To meet the needs raised by WHO and CDC, our laboratory focuses on identification and validation of new molecular targets for the development of gonorrhea treatments (Bonventre, Zielke, Korotkov, & Sikora, [2016](#mbo3432-bib-0008){ref-type="ref"}; Zielke, Wierzbicki, Baarda, & Sikora, [2015](#mbo3432-bib-0079){ref-type="ref"}; Zielke, Wierzbicki, Weber, Gafken, & Sikora, [2014](#mbo3432-bib-0080){ref-type="ref"}; Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"}).

Targeting the first enzymes in the nucleotide‐activated‐*glycero‐manno*‐heptose pathways is a relatively unexplored field, although it appears to be an alternative approach to the discovery of broad‐spectrum antibacterial drugs (Bauer, Stevens, & Hansen, [1998](#mbo3432-bib-0007){ref-type="ref"}; Darby, Ananth, Tan, & Hinnebusch, [2005](#mbo3432-bib-0022){ref-type="ref"}; Tamaki, Sato, & Matsuhashi, [1971](#mbo3432-bib-0065){ref-type="ref"}; Valvano, Messner, & Kosma, [2002](#mbo3432-bib-0071){ref-type="ref"}). Nucleotide‐activated‐*glycero‐manno*‐heptoses, while absent in eukaryotic cells, are widely present in bacteria and are crucial components of the lipopolysaccharides (LPS), lipooligosaccharides (LOS), capsules, O‐antigens, and glycan moieties of bacterial cell surface (S‐layer) glycoproteins (Valvano et al., [2002](#mbo3432-bib-0071){ref-type="ref"}). In particular, one such potential drug target of significant interest is sedoheptulose‐7‐phosphate isomerase, GmhA, annotated previously as TfrA (Havekes, Lugtenberg, & Hoekstra, [1976](#mbo3432-bib-0034){ref-type="ref"}) and LpcA (Brooke & Valvano, [1996a](#mbo3432-bib-0009){ref-type="ref"}). GmhA is conserved in many Gram‐negative and some Gram‐positive bacteria and is responsible for catalyzing isomerization of the D‐sedoheptulose 7‐phosphate into D‐*glycero*‐α,β‐D‐*manno*‐heptose‐7‐phosphate (Eidels & Osborn, [1974](#mbo3432-bib-0027){ref-type="ref"}), which is the first and common step for parallel biosynthetic pathways leading to generation of GDP‐D‐glycero‐α‐D‐*manno*‐heptose (D,D‐heptose) and ADP‐L‐glycero‐β‐D‐*manno*‐heptose \[L,D‐heptose; reviewed in Ref: (Valvano et al., [2002](#mbo3432-bib-0071){ref-type="ref"})\]. D,D‐heptose is required for glycosylation of flagella and capsular polysaccharides, and for the assembly of disaccharide repeating units (D,D‐heptose linked to L‐rhamnose) composing the S‐layer glycan in the Gram‐positive Eubacterium, *Aneurinibacillus thermoaerophilus* DSM 10155 (Eidels & Osborn, [1974](#mbo3432-bib-0027){ref-type="ref"}; Kosma, Wugeditsch, Christian, Zayni, & Messner, [1995](#mbo3432-bib-0044){ref-type="ref"}; Wugeditsch et al., [1999](#mbo3432-bib-0075){ref-type="ref"}). L,D‐heptose is used for glycosylation of capsular polysaccharides (Valvano et al., [2002](#mbo3432-bib-0071){ref-type="ref"}) and as a primary building block of LPS/LOS core oligosaccharide (Brooke & Valvano, [1996a](#mbo3432-bib-0009){ref-type="ref"}; Eidels & Osborn, [1971](#mbo3432-bib-0026){ref-type="ref"}). In addition, a large family of bacterial autotransporter heptosyltransferases (BAHTs) utilizes L,D‐heptose as a sugar donor to modify serine residues on their substrate autotransporters, which has a significant impact on the virulence of Gram‐negative pathogens (Lu, Li, & Shao, [2015](#mbo3432-bib-0047){ref-type="ref"}). The L,D‐heptose is synthesized in sequential reactions catalyzed in order by GmhA‐HldE(HldA)‐GmhB‐HldE(HldC)‐HldD \[reviewed in Refs: (Raetz & Whitfield, [2002](#mbo3432-bib-0058){ref-type="ref"}; Valvano et al., [2002](#mbo3432-bib-0071){ref-type="ref"})\]. Usually one or more L,D‐heptose molecules and two 2‐keto‐3‐deoxy‐D‐*manno*‐oct‐2‐ulosonic acid (KDO) residues form the inner portion (lipid A proximal) of the LPS/LOS core oligosaccharide, which is typically more conserved than the structurally diverse outer core (Raetz & Whitfield, [2002](#mbo3432-bib-0058){ref-type="ref"}). Similarly, gonococcal LOS contain two basal heptose molecules, designated Hep I and Hep II, forming elongation centers α, β, and χ (Gibson et al., [1989](#mbo3432-bib-0031){ref-type="ref"}; John, Griffiss, Apicella, Mandrell, & Gibson, [1991](#mbo3432-bib-0039){ref-type="ref"}; Yamasaki, Bacon, Nasholds, Schneider, & Griffiss, [1991](#mbo3432-bib-0076){ref-type="ref"}). The individual chains can be decorated with structures that mimic human carbohydrate epitopes (α chain linked to Hep I; Apicella & Mandrell, [1989](#mbo3432-bib-0004){ref-type="ref"}); a single glucose, lactose, or glucose with additional sugars (β chain extending from Hep II; Gibson et al., [1989](#mbo3432-bib-0031){ref-type="ref"}; Yamasaki et al., [1994](#mbo3432-bib-0077){ref-type="ref"}); and GlcNac, GlcNac acetate, or occasionally galactose (χ chain; Mcleod Griffiss, Brandt, Saunders, & Zollinger, [2000](#mbo3432-bib-0051){ref-type="ref"}). In addition, phosphate or phosphoethanolamine groups may be attached to the heptose residues (Preston, Mandrell, Gibson, & Apicella, [1996](#mbo3432-bib-0057){ref-type="ref"}; Raetz & Whitfield, [2002](#mbo3432-bib-0058){ref-type="ref"}). The phosphoric residues participate in the ionic interactions between LPS/LOS and outer membrane proteins, as well as divalent cations, providing a barrier against entry of detergents, antibiotics, and hydrophobic compounds (Preston et al., [1996](#mbo3432-bib-0057){ref-type="ref"}; Raetz & Whitfield, [2002](#mbo3432-bib-0058){ref-type="ref"}). The *N. gonorrhoeae* heptose‐monophosphate was recently linked with the clinical and epidemiological synergy of gonorrhea and HIV (Malott et al., [2013](#mbo3432-bib-0048){ref-type="ref"}). At the molecular level, this interplay involves the unique ability of gonococci to efficiently liberate phosphorylated L,D‐heptose into the extracellular milieu, which elicits an immune response and induces HIV‐1 expression and viral production in cluster of differentiation 4‐positive (CD4^+^) T cells (Malott et al., [2013](#mbo3432-bib-0048){ref-type="ref"}).

Mutations in genes encoding GmhA in different bacterial species examined to date resulted in pleiotropic effects including production of truncated LPS/LOS composed of lipid A and KDO residues, increased susceptibility to antibiotics and detergents, impaired biofilm formation, and attenuated virulence (Aballay, Drenkard, Hilbun, & Ausubel, [2003](#mbo3432-bib-0001){ref-type="ref"}; Bauer et al., [1998](#mbo3432-bib-0007){ref-type="ref"}; Brooke & Valvano, [1996b](#mbo3432-bib-0010){ref-type="ref"}; Darby et al., [2005](#mbo3432-bib-0022){ref-type="ref"}). In addition, lack of HldA, which acts immediately downstream from GmhA in the L,D‐heptose biosynthetic pathway, rendered gonococci unable to induce HIV‐1 expression (Malott et al., [2013](#mbo3432-bib-0048){ref-type="ref"}). Therefore, we propose GmhA in *N. gonorrhoeae,* GmhA~GC~, as a molecular target for the development of new antigonococcal drugs. Herein, we performed characterization of GmhA~GC~ at the molecular, functional, and structural levels to facilitate the future targeting of this enzyme with small molecule inhibitors.

2. Experimental Procedures {#mbo3432-sec-0002}
==========================

2.1. Bacterial strains and growth conditions {#mbo3432-sec-0003}
--------------------------------------------

Strains of bacteria used in this study are listed in Table [1](#mbo3432-tbl-0001){ref-type="table-wrap"}. *Neisseria gonorrhoeae* and *N. meningitidis* were cultured either on gonococcal base solid medium (GCB, Difco), or in gonococcal base liquid (GCBL) medium supplemented with Kellogg\'s supplement I and II in ratios 1:100 and 1:1,000, respectively (Spence, Wright, & Clark, [2008](#mbo3432-bib-0063){ref-type="ref"}). GCBL was additionally supplemented with sodium bicarbonate at a final concentration of 0.042%. *In vitro* host‐relevant growth conditions (iron deprivation, presence of normal human serum, anoxia) were procured as described previously (Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"}). *Neisseria* were cultured on solid media for 18--22 hr at 37°C in the presence of 5% atmospheric CO~2~. For *N. gonorrhoeae*, piliated or nonpiliated variants were passaged onto GCB and incubated for additional 18--22 hr. Colonies with piliated morphology were used for DNA transformation, while nonpiliated variants were used in all other experiments. *Escherichia coli* strains were grown either on Luria--Bertani agar (LBA, Difco) or cultured in Luria--Bertani broth (LB, Difco) at 37°C.

###### 

Bacterial strains used in this study

  Bacterial strains                                                                                                                                                              Reference
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------
  *N. gonorrhoeae*                                                                                                                                                               
  FA1090                                                                                                                                                                         (Connell et al., [1988](#mbo3432-bib-0016){ref-type="ref"})
  MS11                                                                                                                                                                           (Meyer, Mlawer, & So, [1982](#mbo3432-bib-0053){ref-type="ref"})
  1291                                                                                                                                                                           (Apicella, Breen, & Gagliardi, [1978](#mbo3432-bib-0003){ref-type="ref"})
  F62                                                                                                                                                                            (Sparling, [1966](#mbo3432-bib-0062){ref-type="ref"})
  FA1090 ∆*gmhA* ~*GC*~/*P* ~*lac*~ *:: gmhA* ~*GC*~                                                                                                                             This study
  FA1090 ∆*gmhA* ~*GC*~/*P* ~*lac*~ *:: gmhA* ~*GC*~ E65A                                                                                                                        This study
  FA1090 ∆*gmhA* ~*GC*~/*P* ~*lac*~ *:: gmhA* ~*GC*~ H183A                                                                                                                       This study
  FA1090 ∆*gmhA* ~*GC*~/*P* ~*lac*~ *:: gmhA* ~*NM*~                                                                                                                             This study
  Baltimore collection 1991--1994:LGB1, LG14, LG2, LGB26, LG20                                                                                                                   (Garvin et al., [2008](#mbo3432-bib-0030){ref-type="ref"}; Zielke et al., [2014](#mbo3432-bib-0080){ref-type="ref"})
  Clinical isolates from Public Health--Seattle & King County Sexually Transmitted Disease Clinic:UW01, UW02, UW03, UW04, UW05, UW06, UW07, UW08, UW09, UW10, UW11, UW12, UW13   (Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"})
  2016 WHO reference strains:F, G, K, L, M, N, O, P, W, X, Y, Z, U, V                                                                                                            (Unemo et al., [2016](#mbo3432-bib-0069){ref-type="ref"})
  *N. meningitidis*                                                                                                                                                              
  MC58                                                                                                                                                                           (McGuinness et al., [1991](#mbo3432-bib-0050){ref-type="ref"})
  MC58 ∆*gmhA* ~*NM*~/*P* ~*lac*~ *:: gmhA* ~*NM*~                                                                                                                               This study
  MC58 ∆*gmhA* ~*NM*~/*P* ~*lac*~ *:: gmhA* ~*GC*~                                                                                                                               This study
  *E. coli*                                                                                                                                                                      
  MC1061                                                                                                                                                                         (Casadaban & Cohen, [1980](#mbo3432-bib-0011){ref-type="ref"})
  BL21(DE3)                                                                                                                                                                      (Studier & Moffatt, [1986](#mbo3432-bib-0064){ref-type="ref"})

John Wiley & Sons, Ltd

Antibiotics were used on selected bacteria in the following concentrations: for *N. gonorrhoeae*: kanamycin 40 μg/ml, erythromycin 0.5 μg/ml; for *N. meningitidis*: kanamycin 80 μg/ml, erythromycin 2 μg/ml; for *E. coli*: kanamycin 50 μg/ml, erythromycin 250 μg/ml.

2.2. Genetic manipulations, site‐directed mutagenesis, and transcomplementation {#mbo3432-sec-0004}
-------------------------------------------------------------------------------

Plasmids and primers used in this study are listed in Table S1. Oligonucleotides were designed based on the genomic sequence of *N. gonorrhoeae* FA1090 (NC_002946), *N. meningitidis* MC58 (NC_003112), and *E. coli* BL21(DE3) (NC_012892) using SnapGene software version 2.8 (GSL Biotech LLC) and synthesized by IDT Technologies. Genomic DNA of gonococcal strains, *N. meningitidis* MC58, and *E. coli* BL21(DE3) was isolated with the Wizard Genomic DNA Purification Kit (Promega). PCR products and plasmid DNA were purified using QIAprep Spin Miniprep Kit (QIAGEN). PCR reactions were performed using chromosomal or plasmid DNA as template, appropriate oligonucleotides, and Q5^®^ High‐Fidelity DNA Polymerase (NEB). *E. coli* MC1061 was used as the host during the molecular cloning and site‐directed mutagenesis procedures. All created constructs and suppressor mutations in ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ were verified by Sanger Sequencing at the Center for Genomic Research and Biocomputing at Oregon State University. Transformation of *N. gonorrhoeae* and *N. meningitidis* was performed as described previously (Alexander, Richardson, & Stojiljkovic, [2004](#mbo3432-bib-0002){ref-type="ref"}; Zielke et al., [2014](#mbo3432-bib-0080){ref-type="ref"}).

The recombinant GmhA~GC~ (rGmhA~GC~) containing N‐terminal‐6 × His‐tag followed by the tobacco etch virus (TEV) protease recognition site was obtained by amplifying the DNA region of the *ngo1986* lacking stop codon with primers rNGO1986‐F and rNGO1986‐R and cloning the obtained PCR product (615 bp) into NcoI/HindIII sites of pRSF‐NT (Table S1).

The conditional GmhA~GC~ mutant, FA1090 ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~, was constructed using a strategy as described by (Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"}) by placing an additional copy of *ngo1986* under the control of the isopropyl β‐D‐1‐thiogalactopyranoside (IPTG)‐inducible promoter, P~*lac*~, within an intergenic region located between *lctP* and *aspC* in the FA1090 chromosome (Mehr, Long, Serkin, & Seifert, [2000](#mbo3432-bib-0052){ref-type="ref"}) and a subsequent in‐frame replacement of the *ngo1986* in its native chromosomal locus with the nonpolar kanamycin resistance cassette. Specifically, the *ngo1986* containing its native ribosomal binding site (RBS) was amplified with primers NGO1986‐RBS‐F and NGO1986‐RBS‐R. The resulting 628 bp PCR product was digested with FseI and inserted into ScaI/FseI‐treated pGCC4, yielding pGCC4‐GmhA~GC~. After transformation of FA1090 with pGCC4‐GmhA~GC~, gonococci were selected on GCB with 0.5 μg/ml erythromycin and verified by PCR with primers pGCC4‐Ver‐F and pGCC4‐Ver‐R.

The constructs for deletion of *gmhA* ~*GC*~ were obtained by amplification of the 552 bp upstream DNA region and 571 bp downstream from *ngo1986* with primers NGO1986‐UP‐F/NGO1986‐UP‐R and NGO1986‐Down‐F/NGO1986‐Down‐R, respectively. The upstream fragment was digested with EcoRI/KpnI and cloned into similarly cleaved pUC18K, yielding pUC18K‐GmhA~GC~‐Up. Next, the downstream fragment was inserted into the BamHI/HindIII‐cleaved pUC18K‐GmhA~GC~‐Up. The resulting pUC18K‐GmhA~GC~ was linearized with HindIII and used to transform FA1090 carrying the second copy of GmhA on the chromosome, FA1090*P* ~*lac*~ *::gmhA* ~*GC*~. Clones were selected on a solid medium supplemented with kanamycin and 0.1 mmol/L IPTG, and verified by PCR with NGO1986‐Ver‐F and NGO1986‐Ver‐R primers. Subsequently, selected gonococci were further verified by immunoblotting analyses using anti‐GmhA~GC~ antisera.

To generate GmhA~GC~E65A and GmhA~GC~H183A, the template for site‐directed mutagenesis (pUC18‐GmhA~GC~) was constructed by amplifying *ngo1986* with its native RBS using primers NGO1986‐RBS‐F and NGO1986‐RBS‐R and cloning into SmaI‐cleaved pUC18. Site‐directed mutagenesis was performed using the template; primer pairs E65A‐F/E65A‐R or H183A‐F/H183A‐R, respectively, and Q5 Site‐Directed Mutagenesis Kit (NEB), according to the manufacturer\'s manual. Subsequently, the mutated variants of GmhA~GC~ were amplified with NGO1986‐RBS‐F and NGO1986‐RBS‐R, cleaved with FseI, cloned into ScaI/FseI‐digested pGCC4, introduced into the FA1090 chromosome, and the native *ngo1986* was deleted as described above.

For transcomplementation studies, GmhA homologs from *N. meningitidis* MC58 (*nmb2090*) and *E. coli* BL21(DE3) (*ECBD_3400*) were amplified with primer pairs NGO1986‐RBS‐F/NGO1986‐RBS‐R and ECBD3400‐RBS‐F, respectively. The resulting PCR products were digested with FseI and introduced into ScaI/FseI‐treated pGCC4. Introduction into the FA1090 chromosome and deletion of GmhA were performed as outlined above.

The cytoplasmic marker control for subfractionation experiments, the *zwf* gene (*ngo0715*) encoding glucose‐6‐phosphate‐1‐dehydrogenase was amplified using primers RAZ548 and RAZ549. The PCR product was cleaved with NcoI and HindIII and cloned into similarly digested pRSF‐NT to obtain plasmid pRSF‐NT‐Zwf.

2.3. Proteome subfractionation procedures {#mbo3432-sec-0005}
-----------------------------------------

Colonies of *N. gonorrhoeae* FA1090 were collected from GCB, suspended in 500 ml of GCBL to OD~600~ of 0.1, and cultured with aeration at 37°C until OD~600~ of \~0.8. Bacterial cells were separated from the suspension by centrifugation (10 min, 6,000*g*, 4°C). The crude cell envelopes were purified using a sodium carbonate extraction procedure while naturally released membrane vesicles (MVs) and soluble proteins (SS) were fractionated from culture supernatants by ultracentrifugation as described previously (Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"}).

2.4. GmhA~GC~ depletion studies {#mbo3432-sec-0006}
-------------------------------

Colonies of FA1090 ∆*gmhA* ~*GC*~/*P* ~*lac*~ *:: gmhA* ~*GC*~ were collected with a cotton swab from GCB supplemented with 10 μmol/L IPTG and suspended in GCBL to OD~600~ of 0.1. After two washes in prewarmed GCBL, bacterial suspension was split and incubated with shaking (220 rpm) with or without IPTG for 3 hr at 37°C. Cultures were back‐diluted to OD~600~ of 0.1 in fresh GCBL, as described above, and cultured for additional 6 hr. At specific time points indicated in the text, OD~600~ measurements were taken, samples for western blotting and LOS isolation were withdrawn, and cultures were serially diluted followed by plating on GCB for enumeration of colony‐forming units (CFUs). Experiments were performed on three separate occasions and mean values and SEM are presented.

2.5. Isolation of LOS and silver staining {#mbo3432-sec-0007}
-----------------------------------------

LOS was isolated from *N. gonorrhoeae* and *N. meningitidis* based on the method described previously (Hitchcock & Brown, [1983](#mbo3432-bib-0035){ref-type="ref"}). Bacteria were either collected from GCB or GCBL, as specified in the text, suspended in 1.5 ml of GCBL to OD~600~ of 0.2 and spun down for 1.5 min at 15,000*g*. Pelleted cells were lysed by addition of 50 μl of lysis buffer (2% SDS, 4% β‐mercaptoethanol, 10% glycerol, 1mol/L Tris‐HCl pH 6.8, and 0.01% bromophenol blue) and incubation at 100°C for 10 min. Samples were allowed to cool down to room temperature and proteins were digested by addition of 25 μg proteinase K in 10 μl of lysis buffer and incubated for 1 hr at 60°C. Isolated LOS was resolved on 16.5% Mini‐PROTEAN^®^ Tris‐Tricine Gel (Bio‐Rad) and visualized by a silver staining procedure (Tsai & Frasch, [1982](#mbo3432-bib-0067){ref-type="ref"}).

2.6. Fitness assessment {#mbo3432-sec-0008}
-----------------------

Colonies of different neisserial strains, as indicated in the text, were collected from GCB and reconstituted in GCBL to OD~600~ of 0.1. Bacterial cultures were incubated in the absence of IPTG for 3 hr at 37°C with aeration and subsequently back‐diluted to OD~600~ of 0.2, serially diluted, and plated on GCB with or without IPTG for CFUs scoring. Experiments were repeated in three biological replicates and mean values with corresponding SEM are presented.

2.7. Purification of the rGmhA~GC~ and rZwf and production of polyclonal rabbit antibodies {#mbo3432-sec-0009}
------------------------------------------------------------------------------------------

*E. coli* BL21(DE3) strain carrying either pRSF‐NT‐GmhA~GC~ or pRSF‐NT‐Zwf was used as heterologous host for overproduction and purification of rGmhA~GC~ and recombinant Zwf (rZwf), respectively. Overnight cultures were back‐diluted in 2.0 L of LB supplemented with kanamycin and incubated with aeration at 37°C until the optical density (OD~600~) reached \~0.5. Overproduction of rGmhA~GC~ and rZwf was induced with 0.1 and 1 mmol/L IPTG, respectively, and cultures were incubated for additional 3 hr at 37°C. Cells were harvested by centrifugation (6,000*g*, 10 min, 4°C). Pelleted bacteria carrying pRSF‐NT‐GmhA~GC~ were suspended in lysis buffer (20 mmol/L Tris‐HCl pH 7.0, 1 mol/L NaCl, 10 mmol/L imidazole, 5% glycerol) supplemented with a Pierce Protease Inhibitor Mini Tablet (Thermo Scientific) and lysed by passaging six times through a French pressure cell at 12,000 psi. Cell debris and unbroken cells were separated from soluble protein fraction by centrifugation at 16,000*g* for 30 min at 4°C. The supernatant was passed through 0.22 μm membrane filter (VWR International) and applied onto Bio‐Scale MiniProfinity IMAC cartridges (Bio‐Rad) on the NGC Scout Chromatography system (Bio‐Rad). Loosely bound proteins were removed with 10 column volumes of wash buffer (20 mmol/L Tris pH 8.0, 500 mmol/L NaCl, 40 mmol/L imidazole) and elutions were conducted with a 40--250 mmol/L imidazole gradient. Fractions containing rGmhA~GC~ were combined and a PD‐10 column (GE Healthcare) was used to exchange the buffer to 20 mmol/L HEPES pH 7.5, 100 mmol/L NaCl, 5% glycerol. Subsequently, the N‐terminal‐6 × His‐tag of the rGmhA~GC~ was removed by TEV protease. Cleavage reaction was prepared by mixing rGmhA~GC~ with TEV in 20:1 (w:w ratio) in 500 μl of cleavage buffer (0.5 mol/L Tris‐HCl pH 8.0, 5 mmol/L EDTA), 10 μl of 0.5 mol/L DTT, and 500 μl of Ni‐NTA agarose (Qiagen) equilibrated with cleavage buffer. Following overnight incubation at room temperature, cleavage mixture was loaded onto a 5 ml polypropylene column (Thermo Scientific) and supernatant containing 6 × His‐tag‐free rGmhA~GC~ was collected. To remove residual TEV protease that coeluted with rGmhA~GC~, the mixture was incubated again with 500 μl of Ni‐NTA agarose (Qiagen) equilibrated with cleavage buffer for 1 hr with rotation at 4°C, and rGmhA~GC~ was eluted. The purified rGmhA~GC~ was applied to a PD‐10 column (GE Healthcare) for a buffer exchange into 20 mmol/L HEPES pH 7.5, 100 mmol/L NaCl, and 5% glycerol.

Purification of rZwf was accomplished using the same procedures as described above with the following modifications. *E. coli* cells were resuspended in lysis buffer (20 mmol/L Tris‐HCl pH 8.0, 10 mmol/L imidazole, 450 mmol/L NaCl). Cells were lysed using French Press and rZwf was purified using 5 ml Bio‐Scale Mini Nuvia IMAC Ni‐Charged column (Bio‐Rad) connected to a NGC Chromatography System (Bio‐Rad). Bound peptides were eluted using elution buffer (20 mmol/L Tris‐HCl pH 8.0, 250 mmol/L imidazole, 450 mmol/L NaCl). Fractions containing proteins were pooled, EDTA and DTT were added to final concentrations of 0.5 mmol/L and 1 mmol/L, respectively, and the His‐tag was removed by overnight incubation with TEV protease (ratio 1:100 w/w). After cleavage, the proteins were separated using Hi Load 16/600 Superdex 75 pg column (GE Healthcare) and buffer containing 20 mmol/L Tris pH 8, 150 mmol/L NaCl connected to the NGC Chromatography System. Fractions containing Zwf were pooled together and concentrated using 10 kDa Vivaspin 20 concentrators (GE Healthcare). Glycerol was added to a final concentration of 10% and the protein was aliquoted and stored at −80°C.

The polyclonal rabbit anti‐GmhA~GC~ and anti‐Zwf antibodies were generated using 6 × His‐tag‐free rGmhA~GC~ and rZwf, respectively. Standard 13‐week antibody production protocols were applied, utilizing four New Zealand White rabbits, animal handling was performed according to the Animal Protocol \#1 approved by IACUC, in a certified animal facility (USDA 93‐R‐283) and the NIH Animal Welfare Assurance Program (\#A4182‐01) at the Pacific Immunology Corporation. Anti‐GmhA~GC~ and anti‐Zwf antisera were used at 1:10,000.

2.8. Size exclusion chromatography {#mbo3432-sec-0010}
----------------------------------

The NGC Scout Chromatography system (Bio‐Rad) employing a HiLoad 16/600 Superdex 75 pg column (GE Healthcare Life Sciences) was used to separate purified rGmhA~GC~ based on the molecular size. Buffer for the chromatography (20 mmol/L Tris‐HCl pH 8.0, 500 mmol/L NaCl) was applied at 1 ml/min flow rate. Gel Filtration Standard (Bio‐Rad) was used to determine the size of the separated proteins.

2.9. Crystallization and structure determination of *N. gonorrhoeae* GmhA~GC~ {#mbo3432-sec-0011}
-----------------------------------------------------------------------------

The screening for initial crystallization conditions was performed using JCSG Core Suites I‐IV (Qiagen) (Newman et al., [2005](#mbo3432-bib-0055){ref-type="ref"}). The optimized crystals were grown using 0.1 mol/L Tris‐HCl pH 8.5, 0.2 mol/L magnesium chloride, 30% PEG4000. Crystals were transferred to a cryoprotectant solution supplemented with 20% glycerol and flash‐frozen in liquid nitrogen. The diffraction data were collected from a single crystal at the beamline 22‐ID, Southeast Regional Collaborative Access Team (SER‐CAT) at the Advanced Photon Source, Argonne National Laboratory. Data were integrated and scaled using *XDS* and *XSCALE* (Kabsch, [2010a](#mbo3432-bib-0040){ref-type="ref"}). The structure was solved by molecular replacement using Phaser (McCoy et al., [2007](#mbo3432-bib-0049){ref-type="ref"}) and structure of *Pseudomonas aeruginosa* GmhA (PDB 3BJZ) as a search model (Taylor et al., [2008](#mbo3432-bib-0066){ref-type="ref"}). The electron density modification was performed using Parrot (Cowtan, [2010](#mbo3432-bib-0020){ref-type="ref"}) followed by automated model rebuilding using Buccaneer (Cowtan, [2006](#mbo3432-bib-0019){ref-type="ref"}). The model was completed by manual rebuilding in *Coot* (Emsley, Lohkamp, Scott, & Cowtan, [2010](#mbo3432-bib-0029){ref-type="ref"}) and was refined using REFMAC5 (Murshudov et al., [2011](#mbo3432-bib-0054){ref-type="ref"}). The structure was validated using *Coot* and the MolProbity server (Chen et al., [2010](#mbo3432-bib-0015){ref-type="ref"}). The structural figures were generated using PyMol (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC.).

2.10. SDS‐PAGE and immunoblotting {#mbo3432-sec-0012}
---------------------------------

Whole cell lysates of *Neisseria* strains indicated in the text were either collected from solid media after 22 hr of aerobic or 48 hr of anaerobic growth, or harvested from liquid media following procedures described (Zielke et al., [2014](#mbo3432-bib-0080){ref-type="ref"}, [2016](#mbo3432-bib-0078){ref-type="ref"}). *E. coli* cells were collected from LB agar plates after overnight incubation. Samples were normalized based on OD~600~ values or based on total protein concentration, and SDS‐PAGE, staining with Coomassie brilliant blue G‐250, and immunoblotting analyses were performed exactly as described previously (Zielke et al., [2014](#mbo3432-bib-0080){ref-type="ref"}, [2016](#mbo3432-bib-0078){ref-type="ref"}).

2.11. Statistical analysis {#mbo3432-sec-0013}
--------------------------

GraphPad Prism\'s build‐in *t*‐test was used for determination of statistically significant differences between obtained experimental results. A confidence level of 95% was used for all analyses.

2.12. Accession numbers {#mbo3432-sec-0014}
-----------------------

The coordinates and structure factors were deposited to the Protein Data Bank with accession code 5I01.

3. Results {#mbo3432-sec-0015}
==========

3.1. Chromosomal location and purification of GmhA~GC~ {#mbo3432-sec-0016}
------------------------------------------------------

Genes encoding the enzymes of L,D‐heptose biosynthesis pathway are scattered throughout the chromosome in the majority of bacteria including *N. gonorrhoeae* (Valvano et al., [2002](#mbo3432-bib-0071){ref-type="ref"}). The GmhA homolog in *N. gonorrhoeae* strain FA1090 is encoded by *ngo1986*, which is located between *ngo1985*, coding for an outer membrane lipoprotein (Zielke et al., [2014](#mbo3432-bib-0080){ref-type="ref"}) and *ngo1987* encoding a putative endonuclease (YraN). Comparison of the *gmhA* location using BioCyc Pathway/Genome Database Collection (<http://biocyc.org/>) showed that this genetic arrangement is conserved among the various deposited *Neisseria* species and isolates (*n *=* *70) with only a few exceptions, including *N. bacilliformis* ATCC BAA‐1200, *N. sp*. oral taxon 020 F0370, *N. shayeganii* 871, and *N. subflava* NJ9703.

GmhA~GC~ consists of 197 amino acids with residues 37--197 comprising a sugar isomerase domain (SIS) (Bateman, [1999](#mbo3432-bib-0006){ref-type="ref"}) that is shared between all ketose/aldose isomerases (Golinelli‐Pimpaneau, Le Goffic, & Badet, [1989](#mbo3432-bib-0032){ref-type="ref"}). At the amino acid level, GmhA~GC~ shows 43--57% identity with crystallized orthologous proteins (Table [3](#mbo3432-tbl-0003){ref-type="table-wrap"}) and contains the key conserved residues observed in all GmhA homologs, including three serine residues and a threonine that presumably interact with the phosphate group of sedoheptulose 7‐phosphate or D‐*glycero*‐D‐*manno*‐heptose 7‐phosphate (Harmer, [2010](#mbo3432-bib-0033){ref-type="ref"}; Valvano et al., [2002](#mbo3432-bib-0071){ref-type="ref"}).

To characterize GmhA~GC~, we first purified recombinant protein with an N‐terminal 6 × His‐tag followed by the tobacco etch virus (TEV) protease cleavage site and prepared untagged protein. Size exclusion chromatography indicated that the native GmhA~GC~ forms tetrameric structures in the solution (Fig. S1A). The denatured protein migrated on SDS‐PAGE according to the predicted molecular mass of 21.093 kDa (Fig. S1B). Untagged GmhA~GC~ was subsequently used in crystallization and to obtain polyclonal rabbit antisera.

3.2. *N. gonorrhoeae* deprived of GmhA~GC~ displays defect in LOS synthesis and growth cessation {#mbo3432-sec-0017}
------------------------------------------------------------------------------------------------

The genetic inactivation of *gmhA* in *E. coli*,*Haemophilus influenzae*,*H. ducreyi*,*Salmonella enterica*, and *Yersinia pestis* resulted in altered outer membrane permeability and decreased virulence in animal infection models, however, the mutants did not display drastic growth defects *in vitro* (Aballay et al., [2003](#mbo3432-bib-0001){ref-type="ref"}; Bauer et al., [1998](#mbo3432-bib-0007){ref-type="ref"}; Brooke & Valvano, [1996b](#mbo3432-bib-0010){ref-type="ref"}; Darby et al., [2005](#mbo3432-bib-0022){ref-type="ref"}). Therefore, we were surprised by the failure of our numerous attempts to generate a clean deletion of *ngo1986* in *N. gonorrhoeae* FA1090. As an alternative strategy, an additional copy of *gmhA* ~GC~ was placed under the control of the IPTG‐inducible *P* ~*lac*~ promoter and introduced into the chromosome of wild‐type FA1090, followed by an allelic replacement of *ngo1986* with the kanamycin resistance cassette. The obtained ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ mutant grew scarcely after passage on solid media without IPTG, whereas abundant colonies were observed in the presence of the inducer (Figure [1](#mbo3432-fig-0001){ref-type="fig"}a). The depletion of GmhA~GC~ was corroborated by probing whole cell lysates of these gonococci with anti‐GmhA~GC~ antisera (Figure [1](#mbo3432-fig-0001){ref-type="fig"}b). Visualization of LOS species by Tricine‐SDS‐PAGE coupled with silver staining showed, as expected, that bacteria deprived of GmhA~GC~ carried a truncated version of LOS that migrated faster in comparison with the LOS species isolated from wild‐type and ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ grown in the presence of IPTG (Figure [1](#mbo3432-fig-0001){ref-type="fig"}b).

![GmhA~GC~ is pivotal for *N. gonorrhoeae* growth and lipooligosaccharide (LOS) synthesis. (a) The *N. gonorrhoeae* FA1090 *gmh* *A*~*GC*~ conditional knockout strain, ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~, was streaked out from frozen glycerol stock on solid media supplemented with 20 μmol/L isopropyl β‐D‐1‐thiogalactopyranoside (IPTG). After 18 hr incubation at 37°C in the presence of 5% atmospheric CO ~2~, the colonies were passaged onto plates either with (+) or without IPTG (−). (b) Whole cell lysates of FA1090 wild‐type and isogenic ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~ harvested from plates with (+) or without 20 μmol/L IPTG (−) were either probed with polyclonal rabbit antisera or subjected to LOS extraction using proteinase K followed by silver staining. (c--e) The FA1090 ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~ cells were collected from solid media supplemented with 20 μmol/L IPTG, suspended to OD ~600~ of 0.1, washed twice, divided, and cultured either in the presence or absence of IPTG for 3 hr. At time point designated as 0 hr, corresponding cultures were back‐diluted to the same density (OD ~600~ of 0.1) into fresh media with or without IPTG and incubated for additional 6 hr. Samples of bacterial cultures were collected every hour for GmhA~GC~ and Ng‐MIP immunoblotting analysis, LOS, and whole cell protein profiles (c), monitoring of bacterial proliferation by measurement of density of the cultures at OD ~600~, (d) and spotting serially diluted bacteria on solid media with IPTG for CFU scoring (e). Whole cell lysates were matched by the same OD ~600~ units. As loading control, samples separated by SDS‐PAGE were either probed with anti‐Ng‐MIP antibodies or stained with Coomassie brilliant blue G‐250. The migration of molecular mass marker (kDa) is indicated on the left. All experiments were performed in three biological replicates. Means and SEM are presented on graphs; \**p *\<* *.05](MBO3-6-na-g001){#mbo3432-fig-0001}

Subsequently, time course experiments under standard laboratory growth conditions were conducted to examine the correlation between depletion of GmhA~GC~, LOS formation, and *N. gonorrhoeae* fitness. An initial suspension of nonpiliated colonies of ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ collected from solid media supplemented with IPTG was divided and cultured in liquid media in the presence or absence of IPTG \[(+) or (−), respectively\]. After 3 hr, to ensure GmhA~GC~ depletion, the corresponding cultures were diluted to OD~600~ of 0.1 in media with or without IPTG. From this point onward (shown as 0 hr in Figure [1](#mbo3432-fig-0001){ref-type="fig"}c--e), samples were withdrawn every hour to assess GmhA~GC~ levels and LOS formation (Figure [1](#mbo3432-fig-0001){ref-type="fig"}c), culture density (Figure [1](#mbo3432-fig-0001){ref-type="fig"}d), and colony forming units (CFUs; Figure [1](#mbo3432-fig-0001){ref-type="fig"}e). Immunoblotting with anti‐GmhA~GC~ antisera showed that in the absence of IPTG, GmhA~GC~ levels were slightly decreased at 0 hr and complete GmhA~GC~ depletion was achieved three hours later (Figure [1](#mbo3432-fig-0001){ref-type="fig"}c). Also, it was noted that despite the presence of inducer, GmhA~GC~ had a peculiar expression pattern; decreased amounts of protein in comparison with these observed at 0 hr were detected at 1 hr and in early‐log phase (corresponding to 2--3 hr data points). Furthermore, increased GmhA~GC~ levels were found in late‐log phase (4, 5 hr) followed by a decline in stationary phase (6 hr; Figure [1](#mbo3432-fig-0001){ref-type="fig"}c--e). In contrast, no major differences were noticed in the overall protein profiles and the level of Ng‐MIP (Figure [1](#mbo3432-fig-0001){ref-type="fig"}c), which is ubiquitously expressed throughout phases of gonococci growth (Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"}). As expected based on data presented in Figure [1](#mbo3432-fig-0001){ref-type="fig"}b, the wild‐type LOS species diminished over time and were barely detectable upon GmhA~GC~ diminution (Figure [1](#mbo3432-fig-0001){ref-type="fig"}c). Finally, analysis of culture density and number of viable gonococci showed that in media lacking IPTG, bacterial growth was greatly reduced concomitant to depletion of GmhA~GC~ (Figure [1](#mbo3432-fig-0001){ref-type="fig"}c--e), whereas in the presence of IPTG, the generation time of the ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ mutant was 61.2 min (Figure [1](#mbo3432-fig-0001){ref-type="fig"}d--e), a value similar to the parental wild‐type strain (56.5 min; Figure [2](#mbo3432-fig-0002){ref-type="fig"}b). In addition, under nonpermissive conditions, we observed that the OD~600~ of the mutant culture continued to increase (Figure [1](#mbo3432-fig-0001){ref-type="fig"}d) while the number of viable bacteria remained at 10^7^ CFUs/ml (Figure [1](#mbo3432-fig-0001){ref-type="fig"}e). These results suggested that suppressors were arising in the mutant population but had not reached the point where they overcome the persistent population by the end of the 6‐hr growth curve. We tested this possibility by passaging ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ on solid media without and with IPTG. After the third passage, ample bacterial colonies were obtained with several mutations within the *P* ~*lac*~ *,* allowing expression of GmhA~GC~ and LOS synthesis (Fig. S2).

![Assessment of GmhA~GC~ subcellular localization and expression patterns. (a) *N. gonorrhoeae* wild‐type FA1090 cells were harvested during mid‐exponential phase and subjected to proteome extraction to separate cytoplasmic/periplasmic proteins (C), cell envelopes (CE), naturally released membrane vesicles (MVs), and soluble proteins in culture supernatants (SS). Individual fractions were loaded based on the total amount of protein (μg) and probed with antisera as indicated on the left. (b--c) Wild‐type *N. gonorrhoeae* FA1090 was cultured in liquid media and at indicated time points, OD ~600~ measurements were taken (b) and samples were withdrawn and processed for immunoblotting analysis of GmhA~GC~ and Ng‐MIP (c). (d) Quantities of GmhA~GC~ and lipooligosaccharide (LOS) in wild‐type FA1090 during *in vitro* conditions relevant to different infection sites \[standard growth under aerobic conditions (SGC), iron deprivation (‐Iron), presence of normal human serum (+NHS), and anaerobiosis (‐O~2~)\], were assessed by probing the whole cell lysates with anti‐GmhA~GC~ antibodies and silver staining of proteinase K‐extracted LOS, respectively. Immunoblotting experiments with antisera against Ng‐MIP, TbpB, and AniA were used as markers for ubiquitous expression, iron‐limiting, and anaerobic conditions, respectively. (e**)** Effect of overexpression of GmhA~GC~ on LOS amounts was examined by harvesting wild‐type FA1090 and isogenic ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~ grown on solid media with different isopropyl β‐D‐1‐thiogalactopyranoside (IPTG) concentrations (0, 20, or 1,000 μmol/L). Whole cell lysates were either probed with anti‐GmhA~GC~ antisera or treated with proteinase K and LOS was visualized by silver staining. Experiments were performed in biological triplicates and representative immunoblots and silver‐stained gels are shown. Mean values and corresponding SEM are presented on the graph. Migration of a molecular mass marker (kDa) is indicated on the left](MBO3-6-na-g002){#mbo3432-fig-0002}

Together, these findings demonstrated that GmhA~GC~ is pivotal for LOS synthesis and optimal growth of *N. gonorrhoeae*.

3.3. GmhA~GC~ subcellular localization and expression patterns {#mbo3432-sec-0018}
--------------------------------------------------------------

Preliminary results and absence of signal peptide suggested that GmhA of *E. coli* is a cytoplasmic enzyme (Brooke & Valvano, [1996a](#mbo3432-bib-0009){ref-type="ref"}). However, subcellular localization of GmhA and expression patterns were never assessed. To examine the localization of GmhA~GC~, *N. gonorrhoeae* FA1090 was harvested at mid‐logarithmic phase of growth and subjected to subfractionation procedures. Equal amounts of extracted proteome fractions including cytoplasm, cell envelopes, naturally released membrane vesicles, and soluble proteins in culture supernatants were separated by SDS‐PAGE and probed with polyclonal antibodies (Figure [2](#mbo3432-fig-0002){ref-type="fig"}a). GmhA~GC~ was found solely in the cytoplasmic protein fraction, similarly to the cytoplasmic enzyme glucose‐6‐phosphate 1‐dehydrogenase, Zwf. As expected, the GTPase Obg (Obg~GC~), which primarily associates with 50S ribosomal subunits and partly with the peripheral inner membrane proteome (Papanastasiou et al., [2013](#mbo3432-bib-0056){ref-type="ref"}; Zielke et al., [2015](#mbo3432-bib-0079){ref-type="ref"}), was detected mainly in the cytoplasm and minute amounts were also found in the cell envelope fraction; whereas, antisera against the outer membrane protein marker BamA (Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"}) cross‐reacted with fractions containing cell envelopes and membrane vesicles.

The expression of GmhA~GC~ was subsequently examined in wild‐type FA1090 during routine aerobic growth in liquid media (Figure [2](#mbo3432-fig-0002){ref-type="fig"}b--c) and on solid media under conditions that more closely mimic clinical infection, such as iron deprivation, exposure to human serum, and anoxia (Figure [2](#mbo3432-fig-0002){ref-type="fig"}d). Antibodies against Ng‐MIP, TbpB, and AniA were used as markers for ubiquitous expression, iron‐limiting conditions, and anaerobiosis, respectively (Cornelissen, [2008](#mbo3432-bib-0017){ref-type="ref"}; Zielke et al., [2014](#mbo3432-bib-0080){ref-type="ref"}, [2016](#mbo3432-bib-0078){ref-type="ref"}). Immunoblotting analyses of whole cell lysates showed that expression of GmhA~GC~ peaked during mid‐exponential phase (3 and 4 hr, Figure [2](#mbo3432-fig-0002){ref-type="fig"}b--c). Increased GmhA~GC~ levels were also detected during iron deprivation and anaerobic growth in comparison with standard laboratory conditions (Figure [2](#mbo3432-fig-0002){ref-type="fig"}d). As expected, expression of Ng‐MIP remained constant throughout different phases of gonococcal growth and was unchanged under all tested conditions (Zielke et al., [2015](#mbo3432-bib-0079){ref-type="ref"}, [2016](#mbo3432-bib-0078){ref-type="ref"}), while TbpB and AniA were the most highly upregulated during iron deprivation and anaerobic growth, respectively (Figure [2](#mbo3432-fig-0002){ref-type="fig"}d).

The increase in GmhA~GC~ expression did not influence LOS migration patterns in wild‐type gonococci, albeit increased amounts of total LOS were observed in bacteria cultured in the presence of normal human serum and anaerobically (Figure [2](#mbo3432-fig-0002){ref-type="fig"}d). To further assess the possible correlation between expression of GmhA~GC~ and LOS levels, ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ was cultured in increasing concentrations of IPTG. The vast overexpression of GmhA~GC~ achieved with 1,000 μmol/L IPTG did not have adverse effect on bacterial growth (data not shown) and had no effect on the LOS quantities (Figure [2](#mbo3432-fig-0002){ref-type="fig"}e).

Cumulatively, these experiments demonstrated that GmhA~GC~ is a cytoplasmic enzyme with augmented expression during mid‐logarithmic phase, iron depletion and anaerobiosis, and that overproduction of GmhA~GC~ alone does not alter gonococcal LOS abundance.

3.4. Conservation of *gmhA* among *Neisseria* {#mbo3432-sec-0019}
---------------------------------------------

Analysis of *gmhA* conservation showed that the gene (locus NGO1986, NMB2090, NMC2070) is present in all of the 39,182 *Neisseria spp*. genomes deposited into the PubMLST database (<http://pubmlst.org/neisseria/> as of July, 20, 2016) and that there are 340 alleles and 323 single nucleotide polymorphic sites (Fig. S4).

Expression of GmhA~GC~ among 36 different *N. gonorrhoeae* strains isolated from patients at different times and geographic locations, including the 2016 WHO reference strains (Unemo et al., [2016](#mbo3432-bib-0069){ref-type="ref"}), was also assessed by immunoblotting. Whole cell lysates were resolved by SDS‐PAGE and probed with either polyclonal anti‐GmhA~GC~ antisera or Zwf antibodies, or stained with Coomassie brilliant blue G‐250 as a loading control. Antisera against GmhA~GC~ cross‐reacted with all clinical isolates of *N. gonorrhoeae*, but no cross‐reactivity was detected for the *E. coli* GmhA homolog (Figure [3](#mbo3432-fig-0003){ref-type="fig"}). In addition, there were noticeable differences in GmhA~GC~ protein abundance between the strains, while Zwf was uniformly expressed and there were no discrepancies in regard to samples normalization and loading (Figure [3](#mbo3432-fig-0003){ref-type="fig"} and Fig. S3).

![GmhA~GC~ expression in a panel of *N. gonorrhoeae* isolates. Whole cell lysates of *E. coli*, wild‐type FA1090, ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~ grown either with (+) or without (−) isopropyl β‐D‐1‐thiogalactopyranoside (IPTG), and 36 additional strains of *N. gonorrhoeae* were resolved on a 10--20% Tris‐Glycine gel and probed with anti‐GmhA~GC~ antibodies. Immunoblotting with anti‐Zwf antisera was used as a loading control. Migration of a molecular mass marker (kDa) is indicated on the left](MBO3-6-na-g003){#mbo3432-fig-0003}

3.5. Hindering GmhA~GC~ isomerase activity does not influence *N. gonorrhoeae* growth {#mbo3432-sec-0020}
-------------------------------------------------------------------------------------

The crucial side chains for GmhA enzymatic activity appeared to be E65 and H180 in the *E. coli* ortholog as analyzed by in vitro kinetic assays, LOS synthesis, and novobiocin sensitivity studies. It has been proposed that these two residues act as the base and the acid, respectively, to promote the isomerization reaction of D‐sedoheptulose 7‐phosphate into D‐*glycero*‐α,β‐D‐*manno*‐heptose‐7‐phosphate (Taylor et al., [2008](#mbo3432-bib-0066){ref-type="ref"}). Therefore, to determine whether the observed decrease in *N. gonorrhoeae* survival upon GmhA~GC~ depletion is a consequence of abolished LOS synthesis, site‐directed mutagenesis of corresponding residues (E65 and H183 in GmhA~GC~) was employed. The obtained GmhA~GC~ E65A and H183A variants were placed under the IPTG‐inducible promoter and introduced into the chromosome of wild‐type FA1090, followed by allelic exchange of *ngo1986* with the kanamycin resistance cassette. Both mutated proteins were stably produced in *N. gonorrhoeae*; however, the H183A variant was present at higher levels than the wild‐type GmhA~GC~ (Figure [4](#mbo3432-fig-0004){ref-type="fig"}a). Silver staining analysis of LOS revealed that bacteria expressing either E65A or H183A constructs produced truncated LOS, regardless of the presence of IPTG (Figure [4](#mbo3432-fig-0004){ref-type="fig"}a). Furthermore, under nonpermissive conditions (without IPTG), the ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~E65A and ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmA* ~*GC*~H183A, similar to the ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~, had decreased viability, which was demonstrated by a 3214‐, and 8653‐fold decline, respectively, in CFUs in comparison with wild‐type gonococci (Figure [4](#mbo3432-fig-0004){ref-type="fig"}b). In contrast, the expression of either mutated version of GmhA~GC~ rescued bacterial viability to the wild‐type level.

![Hindering GmhA~GC~ isomerase activity does not influence *N. gonorrhoeae* growth. (a) Wild‐type FA1090 and isogenic conditional mutants carrying either native *gmh* *A*~*GC*~ (∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~) or mutated variants of GmhA~GC~ (∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~E65A or ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~H183A) were collected from solid media with (+) and without (−) isopropyl β‐D‐1‐thiogalactopyranoside (IPTG). Expression of individual GmhA~GC~ variants and lipooligosaccharide (LOS) patterns were examined in whole cell extracts by immunoblotting and silver staining, respectively. Samples were matched by equivalent OD ~600~ units. Migration of a molecular mass marker (kDa) is indicated on the left. (b) Wild‐type FA1090 and conditional mutants ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~, ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~E65A, and ∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~H183A were collected from solid media supplemented with 20 μmol/L IPTG, suspended in liquid media to OD ~600~ of 0.1, cultured for 3 hr, back‐diluted to equal OD ~600~ of 0.2, serially diluted, and spotted on solid media in the presence (+) and absence (−) of IPTG. CFUs were scored. The data show averages of CFUs with corresponding SEM of at least three separate experiments; \**p *\<* *.05](MBO3-6-na-g004){#mbo3432-fig-0004}

These *in vivo* studies demonstrated the importance of residues E65 and H183 in GmhA~GC~ activity in the production of full‐length LOS and suggested that abolition of LOS synthesis is disconnected from the GmhA~GC~‐dependent effect on *N. gonorrhoeae* viability.

3.6. Transcomplementation studies of GmhA {#mbo3432-sec-0021}
-----------------------------------------

GmhA homologs of *H. influenzae* and *H. ducreyi* restored the synthesis of full‐length LPS in the *E. coli* ∆*gmhA* mutant (Bauer et al., [1998](#mbo3432-bib-0007){ref-type="ref"}; Brooke & Valvano, [1996a](#mbo3432-bib-0009){ref-type="ref"}). This suggested that GmhA proteins can function interchangeably. However, failure of multiple attempts to remove *ngo1986* in FA1090 carrying the *E. coli gmhA* gene cloned under the P~*lac*~ promoter and integrated into the chromosome ruled out the possibility of a functional interspecies complementation. The *E. coli* GmhA (GmhA~EC~) shares 74% and 75% amino acid identity with *H. influenzae* and *H. ducreyi* proteins, respectively, while only 50% identity exists between GmhA~EC~ and GmhA~GC~ (Table [3](#mbo3432-tbl-0003){ref-type="table-wrap"}). In contrast, *N. meningitidis* GmhA (GmhA~NM~) shows 98% identity to GmhA~GC~, and anti‐GmhA~GC~ antisera readily recognized GmhA~NM~ (Figure [5](#mbo3432-fig-0005){ref-type="fig"}a). Therefore, we decided to use an analogous strategy to create *N. gonorrhoeae* and *N. meningitidis* ∆*gmhA* strains expressing either endogenous or nonendogenous GmhA. Immunoblotting experiments demonstrated that under permissive conditions, both proteins were stably expressed in each host, while without IPTG, neither GmhA~GC~ nor GmhA~NM~ were detected (Figure [5](#mbo3432-fig-0005){ref-type="fig"}a). Functional interchangeability of GmhA between *N. gonorrhoeae* and *N. meningitidis* was then evaluated by analysis of LOS patterns. In FA1090, ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*NM*~ expression of GmhA~NM~ resulted in LOS migrating exactly as LOS species extracted from the wild‐type gonococci (Figure [5](#mbo3432-fig-0005){ref-type="fig"}a). Likewise, expression of GmhA~GC~ restored LOS synthesis in the *N. meningitidis* MC58 ∆*gmhA* ~*NM*~/*P* ~*lac*~ *::gmhA* ~*GC*~. Furthermore, as expected from our studies in *N. gonorrhoeae* (Figure [1](#mbo3432-fig-0001){ref-type="fig"}), depletion of GmhA~NM~ in *N. meningitidis* MC58 ∆*gmhA* ~*NM*~/*P* ~*lac*~ *::gmhA* ~*NM*~ had adverse effects on bacterial viability and resulted in a 300‐ and 235.7‐fold decrease in CFUs in comparison with wild‐type and ∆*gmhA* ~*NM*~/*P* ~*lac*~ *::gmhA* ~*NM*~ cultured in the presence of IPTG, respectively (Figure [5](#mbo3432-fig-0005){ref-type="fig"}b). There was no statistically significant difference in the number of CFUs between the wild‐type *N. gonorrhoeae* and its isogenic ∆*gmhA* ~*GC*~ mutant expressing either GmhA~GC~ or GmhA~NM~ (Figure [5](#mbo3432-fig-0005){ref-type="fig"}b). Similarly, both GmhA~NM~ and GmhA~GC~ fully complemented the lack of GmhA~NM~ in *N. meningitidis*.

![Homologs of GmhA from *N. gonorrhoeae* and *N. meningitidis* function interchangeably. (a) *N. gonorrhoeae* FA1090 wild‐type and isogenic conditional *gmhA* mutants bearing either endogenous (∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*GC*~) or *N. meningitidis*‐derived *gmh* *A*~*NM*~ (∆*gmh* *A*~*GC*~/*P* ~*lac*~ *::gmh* *A*~*NM*~), as well as *N. meningitidis* MC58 wild‐type and conditional *gmhA* mutants carrying *gmhA* alleles (∆*gmh* *A*~*NM*~/*P* ~*lac*~ *::gmh* *A*~*NM*~ or ∆*gmh* *A*~*NM*~/*P* ~*lac*~ *::gmh* *A*~*GC*~) were harvested from GCB after 22 hr of incubation either with (+) or without (−) isopropyl β‐D‐1‐thiogalactopyranoside (IPTG). Whole cell lysates were probed with anti‐GmhA~GC~ antibodies or treated with proteinase K and lipooligosaccharide (LOS) was visualized by silver staining. Migration of a molecular mass marker (kDa) is indicated on the left. (b) Wild‐type and mutant strains of *N. gonorrhoeae* and *N. meningitidis,* as described above, were collected from GCB supplemented with 20 μmol/L IPTG and 15 μmol/L IPTG, respectively. Bacteria were suspended in gonococcal base liquid (GCBL) to OD ~600~ of 0.1, cultured for 3 hr, back‐diluted to equal OD ~600~ of 0.2, serially diluted, and plated on GCB with (+) and without (−) IPTG. CFUs were counted following 22 hr of incubation. Experiments were performed in three independent replicates. Mean values and SEM are presented; \**p *\<* *.05](MBO3-6-na-g005){#mbo3432-fig-0005}

Together, the transcomplementation studies showed that the *N. gonorrhoeae* and *N. meningitidis* GmhA can function interchangeably. Expression of either of the homologs restored both viability and LOS synthesis. Additionally, we concluded that *E. coli* GmhA~EC~ is not able to complement GmhA~GC~ functions, as we were not able to generate a viable *N. gonorrhoeae* ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*EC*~ mutant.

3.7. The structure of *N. gonorrhoeae* GmhA {#mbo3432-sec-0022}
-------------------------------------------

To gain insights into the function of GmhA~GC~ and to facilitate the future targeting of this enzyme with small molecule inhibitors, we obtained recombinant protein for structural studies (Fig. S1). The structure of *N. gonorrhoeae* GmhA was determined by molecular replacement and was refined to 2.37 Å resolution with *R* ~work~ 0.207, *R* ~free~ 0.267, and excellent stereochemical parameters (Table [2](#mbo3432-tbl-0002){ref-type="table-wrap"}). Four monomers of GmhA~GC~ were present in the asymmetric unit (Figure [6](#mbo3432-fig-0006){ref-type="fig"}a). The tetrameric architecture is consistent with the results of size exclusion chromatography (Fig. S1A), and with the previously determined structures of GmhA homologs from other bacteria (Table [3](#mbo3432-tbl-0003){ref-type="table-wrap"}). The interface area of the GmhA~GC~ tetramer is extensive and buries 14,160 Å^2^ of surface area as calculated by the PISA server (Krissinel & Henrick, [2007](#mbo3432-bib-0045){ref-type="ref"}). Four subunits of GmhA~GC~ adopt highly similar structures with root mean square deviation (r.m.s.d.) 0.1--0.2 Å between subunits. Residues 69--74 (chains A and B) and 69--75 (chains C and D) are disordered in the structure. These residues form a loop in the vicinity of the active site and could become ordered upon substrate binding. A similar disorder was observed in the homologous region of *E. coli* GmhA (Taylor et al., [2008](#mbo3432-bib-0066){ref-type="ref"}).

###### 

Data collection and refinement statistics

                                                                         *N. gonorrhoeae* GmhA~GC~ (PDB 5I01)
  ---------------------------------------------------------------------- ----------------------------------------------------------------
  Data collection                                                        
  Wavelength (Å)                                                         1.0000
  Space group                                                            *P*2~1~2~1~2
  Cell dimensions:                                                       
  *a*,*b*,*c* (Å)                                                        114.36, 130.15, 47.15
  α, β, γ (°)                                                            90, 90, 90
  Resolution (Å)                                                         85.91--2.37 (2.43--2.37)[a](#mbo3432-note-0001){ref-type="fn"}
  *R* ~sym~                                                              0.134 (1.032)
  CC~1/2~ [b](#mbo3432-note-0002){ref-type="fn"}                         99.6 (62.4)
  *I*/σ*I*                                                               9.3 (1.7)
  Completeness (%)                                                       95.8 (97.8)
  Multiplicity                                                           3.7 (3.6)
  Refinement                                                             
  Resolution (Å)                                                         85.91--2.37
  No. reflections (total/free)                                           28191/1405
  *R* ~work~/*R* ~free~                                                  0.207/0.267
  Number of atoms:                                                       
  Protein                                                                5411
  Ligand/ion                                                             4
  Water                                                                  101
  *B*‐factors:                                                           
  Protein                                                                37.6
  Ligand/ion                                                             54.9
  Water                                                                  32.7
  All atoms                                                              37.2
  Wilson *B*                                                             41.2
  R.m.s. deviations:                                                     
  Bond lengths (Å)                                                       0.009
  Bond angles (°)                                                        1.224
  Ramachandran distribution[c](#mbo3432-note-0003){ref-type="fn"} (%):   
  Favored                                                                97.8
  Outliers                                                               0

Values in parentheses are for the highest resolution shell.

CC~1/2~ correlation coefficient as defined in (Karplus & Diederichs, [2012](#mbo3432-bib-0042){ref-type="ref"}) and calculated by *XSCALE* (Kabsch, [2010b](#mbo3432-bib-0041){ref-type="ref"}).

Calculated using the MolProbity server (<http://molprobity.biochem.duke.edu>) (Chen et al., [2010](#mbo3432-bib-0015){ref-type="ref"}).

John Wiley & Sons, Ltd

![The structure of *N. gonorrhoeae* GmhA~GC~. (a) The ribbon representation of GmhA~GC~ tetramer with monomers colored in green, yellow, cyan, and magenta. Zn^2+^ ions are shown as gray spheres. (b**)** The structure of GmhA~GC~ monomer is colored in rainbow colors from blue (N‐terminus) to red (C‐terminus). The α‐helices are labeled according to Seetharaman et al., [2006](#mbo3432-bib-0061){ref-type="ref"}. **(**c**)** A close‐up view of the Zn^2+^‐binding site of GmhA~GC~. The coordinating side chains are shown in stick representation. The σ~A~‐weighted 2*F*~O~--*F*~C~ electron density map countered at 1.0 σ is displayed as blue mesh](MBO3-6-na-g006){#mbo3432-fig-0006}

###### 

Structural homologs of *N. gonorrhoeae* GmhA~GC~

  Protein   Organism               r.m.s.d.[a](#mbo3432-note-0004){ref-type="fn"}   Sequence identity[a](#mbo3432-note-0004){ref-type="fn"} (%)   Ligands                                                     PDB ID   Reference
  --------- ---------------------- ------------------------------------------------ ------------------------------------------------------------- ----------------------------------------------------------- -------- -----------------------------------------------------------------
  GmhA      *P. aeruginosa*        0.5                                              57                                                            D‐*glycero*‐α‐D‐*manno*‐heptopyranose‐7‐phosphate           1X92     (Taylor et al., [2008](#mbo3432-bib-0066){ref-type="ref"})
  DiaA      *E. coli*              0.7                                              52                                                            apo                                                         2YVA     (Keyamura et al., [2007](#mbo3432-bib-0043){ref-type="ref"})
  DiaA      *E. coli*              0.7                                              52                                                            apo                                                         4U6N     unpublished
  GmhA      *F. tularensis*        0.7                                              45                                                            apo                                                         3TRJ     (Chaudhury et al., [2013](#mbo3432-bib-0014){ref-type="ref"})
  GmhA      *C. psychrerythraea*   0.7                                              48                                                            apo                                                         5BY2     (Do et al., [2015](#mbo3432-bib-0023){ref-type="ref"})
  GmhA      *C. jejuni*            0.7                                              54                                                            apo                                                         1TK9     (Seetharaman et al., [2006](#mbo3432-bib-0061){ref-type="ref"})
  GmhA      *P. aeruginosa*        0.8                                              56                                                            apo                                                         3BJZ     (Taylor et al., [2008](#mbo3432-bib-0066){ref-type="ref"})
  GmhA      *B. pseudomallei*      0.8                                              43                                                            Zn^2+^                                                      2X3Y     (Harmer, [2010](#mbo3432-bib-0033){ref-type="ref"})
  GmhA      *B. pseudomallei*      0.9                                              43                                                            Zn^2+^, D‐*glycero*‐α‐D‐*manno*‐heptopyranose‐7‐phosphate   2XBL     (Harmer, [2010](#mbo3432-bib-0033){ref-type="ref"})
  GmhA      *E. coli*              1.4                                              45                                                            apo                                                         2I2W     (Taylor et al., [2008](#mbo3432-bib-0066){ref-type="ref"})
  GmhA      *E. coli*              1.1                                              45                                                            D‐sedoheptulose‐7‐phosphate                                 2I22     
  GmhA      *V. cholerae*          1.1                                              43                                                            apo                                                         1X94     (Seetharaman et al., [2006](#mbo3432-bib-0061){ref-type="ref"})

As reported by the Dali server (Holm & Rosenstrom, [2010](#mbo3432-bib-0036){ref-type="ref"}) for superposition of monomers. A mean value is listed for the structures containing more than one protein subunit in the asymmetric unit.

John Wiley & Sons, Ltd

Each monomer of GmhA~GC~ is composed of a central five‐stranded parallel β‐sheet flanked by four α‐helices from each side (Figure [6](#mbo3432-fig-0006){ref-type="fig"}b). Four zinc ions are present in the GmhA~GC~ tetramer. The zinc ions are coordinated by the side chains of residues H61, E65, and H183 of one monomer, and the side chain of Q175 of the neighboring monomer (Figure [6](#mbo3432-fig-0006){ref-type="fig"}c). Therefore, the zinc‐binding sites of GmhA~GC~ are identical to the zinc‐binding sites of *B. pseudomallei* GmhA (Harmer, [2010](#mbo3432-bib-0033){ref-type="ref"}).

Overall, the structure of GmhA~GC~ is similar to the previously determined structures of GmhA from other bacteria, as well as *E. coli* DiaA (Table [3](#mbo3432-tbl-0003){ref-type="table-wrap"}). The monomer structure of GmhA~GC~ could be superimposed to the homologous structures with r.m.s.d. of 0.5--1.4 Å. The tetramer structure of GmhA~GC~ forms a "closed" conformation, similar to the GmhA structures of *P. aeruginosa*,*V. cholerae*,*B. pseudomallei*, and *C. psychrerythraea* (Do et al., [2015](#mbo3432-bib-0023){ref-type="ref"}; Harmer, [2010](#mbo3432-bib-0033){ref-type="ref"}; Seetharaman et al., [2006](#mbo3432-bib-0061){ref-type="ref"}; Taylor et al., [2008](#mbo3432-bib-0066){ref-type="ref"}).

4. Discussion {#mbo3432-sec-0023}
=============

GmhA is a conserved sedoheptulose‐7‐phosphate isomerase involved in the first biosynthesis step of the L,D‐heptose component of the LPS/LOS. Deprivation of heptoses results in pleiotropic phenotypes including synthesis of LPS/LOS molecules composed only of lipid A and KDO residues, increased susceptibility to antimicrobial agents, defects in plasmid F conjugations and P1 bacteriophage transduction, and decreased virulence and biofilm formation (Bauer et al., [1998](#mbo3432-bib-0007){ref-type="ref"}; Brooke & Valvano, [1996a](#mbo3432-bib-0009){ref-type="ref"}; Earl et al., [2015](#mbo3432-bib-0025){ref-type="ref"}; Havekes et al., [1976](#mbo3432-bib-0034){ref-type="ref"}; Malott et al., [2013](#mbo3432-bib-0048){ref-type="ref"}; Tamaki et al., [1971](#mbo3432-bib-0065){ref-type="ref"}). In *N. gonorrhoeae*, heptoses are also crucial for LOS function in the evasion of the host immune system and induction of HIV expression (Malott et al., [2013](#mbo3432-bib-0048){ref-type="ref"}; Preston et al., [1996](#mbo3432-bib-0057){ref-type="ref"}). Variability in LOS molecules on the gonococcal surface is driven by phase variable enzymes responsible for decorating the sugar moiety of the outer core oligosaccharide (Apicella et al., [1987](#mbo3432-bib-0005){ref-type="ref"}; Danaher et al., [1995](#mbo3432-bib-0021){ref-type="ref"}). *N. gonorrhoeae* scavenges sialic acid from the human body and modifies the lacto‐*N*‐neotetraose attached to the HepI of the LOS core oligosaccharide, which provides protection from killing by classical and alternative complement pathways (Elkins et al., [1992](#mbo3432-bib-0028){ref-type="ref"}; Ram et al., [1998](#mbo3432-bib-0059){ref-type="ref"}). Thus, inhibition of GmhA could aid in treatment of infections caused by different pathogenic bacteria including *N. gonorrhoeae*.

Accordingly, in this work, we presented initial characterization of GmhA~GC~ at the functional and structural levels. Our experiments demonstrated that gonococci and meningococci depleted in GmhA produced overall significantly less LOS molecules that migrated faster in comparison with the LOS‐derived from wild‐type bacteria (Figures [1](#mbo3432-fig-0001){ref-type="fig"}b and [5](#mbo3432-fig-0005){ref-type="fig"}a). In contrast to other orthologs, however, diminution of the GmhA cellular pool had severe consequences on neisserial growth (Figures [1](#mbo3432-fig-0001){ref-type="fig"}a, d--e and [5](#mbo3432-fig-0005){ref-type="fig"}b). This protein is likely not essential for bacterial viability, as GmhA*‐*depleted neisserial cells still arose on solid media under nonpermissive conditions (Figure [1](#mbo3432-fig-0001){ref-type="fig"}a, d--e). Corroborating this observation, *gmhA* ~*GC*~ was not found among 827 gonococcal core essential genes identified using a high‐density Tn5 transposon library (Remmele et al., [2014](#mbo3432-bib-0060){ref-type="ref"}). In addition, expression of GmhA~GC~ variants carrying substitutions in the catalytic residues coordinating zinc ions, E65, and H183 (Figure [6](#mbo3432-fig-0006){ref-type="fig"}c), led to synthesis of truncated LOS while retaining ample *N. gonorrhoeae* viability (Figure [4](#mbo3432-fig-0004){ref-type="fig"}). These findings suggested that GmhA~GC~ may be involved in additional physiological function(s) in *Neisseria*. Not surprisingly, a complete functional transcomplementation was achieved between GhmA~GC~ and GmhA~NM~ (Figure [5](#mbo3432-fig-0005){ref-type="fig"}a--b), whereas multiple attempts to generate a viable strain of *N. gonorrhoeae* expressing only GmhA~EC~ were unsuccessful (data not shown). Based on these findings, we concluded that GmhA plays a critical role in LOS synthesis and is a fundamental growth factor for both *N. gonorrhoeae* and *N. meningitidis*.

Profiling of GmhA~GC~ expression showed that amounts of GmhA~GC~ increased during exponential growth of wild‐type *N. gonorrhoeae* (Figure [2](#mbo3432-fig-0002){ref-type="fig"}c). Surprisingly, the isogenic conditional ∆*gmhA* ~*GC*~/*P* ~*lac*~ *::gmhA* ~*GC*~ mutant cultured in the presence of IPTG had elevated levels of GmhA~GC~ during the late logarithmic phase (Figure [1](#mbo3432-fig-0001){ref-type="fig"}c--e), suggesting that expression of GmhA~GC~ is regulated at the posttranscriptional (e.g., small noncoding RNAs, RNA‐binding proteins, RNases, and thermos‐switches) or posttranslational levels. Higher amounts of GmhA~GC~ were also noted upon exposure of *N. gonorrhoeae* to environmental cues relevant to infection; iron deprivation and anaerobiosis (Figure [2](#mbo3432-fig-0002){ref-type="fig"}d). Transcriptomic studies, however, did not identify GmhA~GC~ as an iron‐regulated gene (Ducey, Carson, Orvis, Stintzi, & Dyer, [2005](#mbo3432-bib-0024){ref-type="ref"}; Jackson et al., [2010](#mbo3432-bib-0038){ref-type="ref"}). The observed upregulation of GhmA~GC~ under anaerobic conditions was in agreement with deep sequencing analysis of the *N. gonorrhoeae* anaerobic stimulon, where *gmhA* ~*GC*~ was found to be 4.2‐ and 6.1‐fold upregulated in two biological experiments (Isabella & Clark, [2011](#mbo3432-bib-0037){ref-type="ref"}). Higher levels of enzymes acting downstream from GmhA including HldA (NGO0402) and GmhB (NGO2070) were identified in anaerobically versus aerobically cultured gonococci in our recent high‐throughput proteomic studies (Zielke et al., [2016](#mbo3432-bib-0078){ref-type="ref"}), suggesting that the L,D‐heptose biosynthesis pathway is upregulated during anoxia. Accordingly, increased amounts of LOS were detected in anaerobically grown gonococci (Figure [2](#mbo3432-fig-0002){ref-type="fig"}d), while vast overexpression of GhmA~GC~ alone had no effect on LOS levels (Figure [2](#mbo3432-fig-0002){ref-type="fig"}e). GmhA~GC~ expression was also studied in a diverse collection of gonococcal isolates, including the 2016 WHO reference strains (Unemo et al., [2016](#mbo3432-bib-0069){ref-type="ref"}) containing multidrug‐resistant *N. gonorrhoeae* (Figure [3](#mbo3432-fig-0003){ref-type="fig"}). Potential involvement of GmhA in antibiotic resistance via increased synthesis of LPS was suggested recently in *Salmonella typhimurium* DT104B multiresistant strain with additional fluoroquinolone resistance (Correia et al., [2016](#mbo3432-bib-0018){ref-type="ref"}). Notwithstanding this suggestion, the amounts of GmhA~GC~ varied widely between the WHO strains K, L, V, W, X, Y, and Z, which display overall high levels of ciprofloxacin resistance (MIC\>32 mg/L) and decreased susceptibility to gemifloxacin and moxifloxacin (Unemo et al., [2016](#mbo3432-bib-0069){ref-type="ref"}). Additionally, strain L, which has high MICs for all quinolones (MICs in mg/L for ciprofloxacin, gemifloxacin, and moxifloxacin of \>32, 8, and 16, respectively), showed significantly lower GmhA~GC~ levels in comparison with WHO isolates F, O, P, and U, which are all ciprofloxacin sensitive (MIC of 0.004 mg/L) and are significantly more sensitive to gemifloxacin and moxifloxacin (MICs ranging from 0.004 to 0.016 mg/L).

Finally, to better understand the pivotal function of GmhA~GC~, we have determined the three‐dimensional structure of the untagged enzyme (Figure [6](#mbo3432-fig-0006){ref-type="fig"}). Comparison of our GmhA~GC~ crystal structure with the structures of homologs from other bacteria did not reveal significant differences in the general organization of the structure or within the catalytic site of the enzyme. Zinc ions were not added to any of the protein purification steps or crystallization buffers, yet similar to *Burkholderia pseudomallei* GmhA (Harmer, [2010](#mbo3432-bib-0033){ref-type="ref"}), GmhA~GC~ held zinc ions in the active site (Figure [6](#mbo3432-fig-0006){ref-type="fig"}c), providing further support that GmhA is a metalloenzyme. Zinc is likely retained from the cell of the heterologous host during protein overproduction and natively bound to the active site of the enzyme. Zinc binding likely drives the "closed" conformation of GmhA~GC~, which was also observed in structures of *B. pseudomallei*,*P. aeruginosa*, and *V. cholerae* GmhA (Table [3](#mbo3432-tbl-0003){ref-type="table-wrap"}), thus providing further support that the "closed" conformation is catalytically relevant. In addition, site‐directed mutagenesis coupled with *in vivo* studies confirmed the pivotal function of GmhA~GC~ E65 and H183 in the isomerization of the sedoheptulose‐7‐phosphate (Figures [4](#mbo3432-fig-0004){ref-type="fig"} and [6](#mbo3432-fig-0006){ref-type="fig"}).

In conclusion, understanding the function and structure of individual GmhA proteins will facilitate drug discovery approaches focused on targeting this protein with small molecule inhibitors. In particular, our work demonstrated the crucial function of GmhA in neisserial growth and LOS synthesis, positive regulation of expression by host‐relevant environmental stimuli, and conservation among different isolates, as well as provided further support for the mode of action of GmhA. These findings underscore the significance of GmhA~GC~ as a target for antigonorrhea therapeutics. Future work involving determining the interacting partner(s) of GmhA~GC~ and analysis of global changes at the proteome and metabolome levels are required to elucidate the whole scope of physiological function(s) of GmhA~GC~ in *N. gonorrhoeae*.
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